GSK plc (FRA:GS71)

Germany flag Germany · Delayed Price · Currency is EUR
16.20
+0.16 (1.00%)
At close: Jul 28, 2025, 10:00 PM CET
1.00%
Market Cap65.11B
Revenue (ttm)37.69B
Net Income (ttm)3.77B
Shares Outn/a
EPS (ttm)0.91
PE Ratio17.27
Forward PE8.22
Dividend0.74 (4.60%)
Ex-Dividend DateMay 15, 2025
Volume111,405
Average Volume534,480
Open16.30
Previous Close16.04
Day's Range16.14 - 16.35
52-Week Range14.49 - 19.97
Betan/a
RSI46.61
Earnings DateJul 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a... [Read more]

Industry Pharmaceutical Preparations
Founded 1715
Employees 68,629
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GS71
Full Company Profile

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.